SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-002881
Filing Date
2024-05-01
Accepted
2024-05-01 16:05:13
Documents
13
Period of Report
2024-04-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 33038
  Complete submission text file 0001683168-24-002881.txt   206615

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pmcb-20240429.xsd EX-101.SCH 3079
3 XBRL LABEL FILE pmcb-20240429_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pmcb-20240429_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3679
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 24902910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)